prolaio eVO2peak Module vs Aorta-CAD
AI Verdict
Choose prolaio eVO2peak Module if…
Choose Prolaio eVO2peak Module if you need to longitudinally monitor and estimate a patient's peak oxygen consumption (eVO2peak) using data from FDA-cleared wearable medical sensors. This tool is ideal for cardiovascular research and care settings where assessing functional capacity and tracking changes over time with real-world patient data is crucial.
View prolaio eVO2peak Module →Choose Aorta-CAD if…
Choose Aorta-CAD if your primary goal is to enhance the detection of Aortic Atherosclerosis and Aortic Ectasia directly from chest X-rays within your existing radiology workflow. This AI-powered software is best suited for radiologists and PCPs seeking an adjunctive aid to improve the accuracy and reduce misses in interpreting frontline diagnostic imaging for aortic conditions.
View Aorta-CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | prolaio eVO2peak Module | Aorta-CAD |
|---|---|---|
| Deployment | Cloud | Cloud-based software that integrates into existing chest X-ray workflows and Picture Archiving and Communication System (PACS) viewers. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Aorta-CADTool B, Aorta-CAD, is designed to integrate seamlessly into existing X-ray reading workflows and provides annotations via an overlay that can be toggled on/off, suggesting a highly intuitive and non-disruptive user experience for radiologists and PCPs. Tool A, Prolaio eVO2peak Module, processes data from remote wearable sensors, which, while valuable, might introduce additional steps for data collection and input compared to Tool B's direct integration into a common diagnostic workflow.
Clinical Value
Aorta-CADBoth tools offer significant clinical value. However, Tool B, Aorta-CAD, has demonstrated a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta in clinical studies, directly improving diagnostic accuracy for critical conditions on a widely used imaging modality. Tool A provides an estimate of peak oxygen consumption (eVO2peak) as an adjunctive aid, which is important for cardiovascular assessment but lacks specific outcome metrics in the provided data to compare directly with Tool B's demonstrated reduction in diagnostic errors.
Pricing & Value
TieBoth Prolaio eVO2peak Module and Aorta-CAD require direct contact for pricing information, with no public details available for either product. Without transparent pricing or specific value propositions beyond their core features, it is not possible to differentiate between the two tools on this dimension.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and having Business Associate Agreements (BAAs) in place. Both are also deployed as cloud-based, software-only solutions, indicating similar infrastructure and compliance profiles suitable for healthcare organizations.
Innovation
prolaio eVO2peak ModuleWhile both tools leverage deep learning and are FDA-cleared, Tool A, Prolaio eVO2peak Module, stands out for its innovative approach to estimating a complex physiological parameter like peak oxygen consumption (eVO2peak) using multi-modal real-world patient data, including demographic information, single-lead ECG, and triaxial accelerometry from wearable sensors. This represents a novel application of AI for continuous, non-invasive physiological monitoring. Tool B's application of deep learning to chest X-rays for aortic conditions, while valuable, is a more established area of AI in radiology.
Support & Docs
TieNeither the provided structured facts nor readily available public information from web searches offer specific details regarding the level of customer support, available documentation, or training resources for either Prolaio eVO2peak Module or Aorta-CAD. Therefore, it is not possible to distinguish between the two tools on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | prolaio eVO2peak Module | Aorta-CAD |
|---|---|---|
| Name | prolaio eVO2peak Module | Aorta-CAD |
| Company | Prolaio | Imagen Technologies |
| Primary Function | Estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care. | Assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays. |
| Input Data/Modality | Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors | Chest X-rays |
| Key Technology | Locked deep-learning model, proprietary algorithms | Deep learning algorithms |
| Specialties | Cardiology, Physical Medicine & Rehab, Sports Medicine | Cardiology, Internal Medicine, Radiology |
Videos
Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and Aorta-CAD.